Pharmaceutical Industry Research Insights - World Pharma Today

The Engine of Cell Therapy Success: Why Analytical Development Determines Whether Promising Cell Therapies Reach Patients

Yuvraj — Fri, 12 Jun 2026 09:57:32 +0000

How advanced analytical methods, potency assays, and immune profiling are shaping the future of cancer cell therapies Cell therapies have transformed the treatment landscape for patients with cancer and other serious diseases. Innovations such as CAR-T cell therapies have demonstrated remarkable clinical success, offering new treatment options for patients with limited alternatives. While much of […]

The post The Engine of Cell Therapy Success: Why Analytical Development Determines Whether Promising Cell Therapies Reach Patients first appeared on World Pharma Today.

Toward Net‑Zero Medicines: A Practical Blueprint for Sustainability in the Pharmaceutical Industry

Yuvraj — Tue, 31 Mar 2026 12:23:33 +0000

Sustainability in the pharmaceutical industry is critical because the sector operates at the pivotal intersection of human and planetary health. Medicines save lives, yet their production is energy‑intensive, water‑demanding, and materials‑heavy, with global supply chains that generate significant Scope 1–3 emissions. As climate risks grow, regulators, investors, and patients increasingly expect pharma to lead in […]

The post Toward Net‑Zero Medicines: A Practical Blueprint for Sustainability in the Pharmaceutical Industry first appeared on World Pharma Today.

CMS Extends GENEROUS MFN Drug Pricing Deadline to April

Yuvraj — Tue, 03 Mar 2026 13:10:36 +0000

The Centers for Medicare & Medicaid Services (CMS) in the US has moved to extend the enrolment window for its GENEROUS pilot programme, an initiative aimed at introducing most-favoured-nation (MFN) pricing for outpatient drugs reimbursed by Medicaid. The agency has revised the participation deadline, shifting it from the end of this month to 30th April. […]

The post CMS Extends GENEROUS MFN Drug Pricing Deadline to April first appeared on World Pharma Today.

How APAC Biotech Plans to Turn 2026 Trends into Innovation While Managing Risk?

Yuvraj — Wed, 14 Jan 2026 12:18:32 +0000

Asia-Pacific’s biotechnology landscape is not just growing it is transforming. In 2026, the region stands at a unique crossroads where scientific ambition meets real-world demands. This year will test the industry’s resilience, shape global health priorities, and redefine how biotechnology impacts everyday lives. After more than a decade observing this market, I can confidently say […]

The post How APAC Biotech Plans to Turn 2026 Trends into Innovation While Managing Risk? first appeared on World Pharma Today.

Redefining Success Metrics in Pharma Portfolio Management

Yuvraj — Fri, 26 Dec 2025 09:17:28 +0000

Shift from traditional R&D metrics focused on milestone completion and budget adherence to outcome-based, value-focused metrics that measure strategic impact, learning velocity, and long-term portfolio health while aligning organizational behavior with strategic objectives.

The post Redefining Success Metrics in Pharma Portfolio Management first appeared on World Pharma Today.

Building Resilient Pharma Portfolios in an Era of Scientific and Market Uncertainty

Yuvraj — Wed, 24 Dec 2025 08:26:57 +0000

Pharmaceutical companies are radically redesigning portfolio strategies to survive a "triple threat" environment of scientific complexity, regulatory upheaval like the IRA, and capital scarcity. This analysis explores the shift from efficiency-driven models to resilience-first frameworks, detailing how leaders are embedding optionality into pipelines, embracing modality agnosticism, and using dynamic resource allocation to thrive amidst volatility.

The post Building Resilient Pharma Portfolios in an Era of Scientific and Market Uncertainty first appeared on World Pharma Today.

Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression

Yuvraj — Mon, 17 Nov 2025 08:11:53 +0000

Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical research. This innovative method leverages quantitative gene expression analysis to assess drug efficacy rapidly and cost effectively. Dr. Robert Bissonnette, Executive Chairman and Founder of Indero, who initiated […]

The post Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression first appeared on World Pharma Today.

New data from Elsevier finds one in three corporate researchers have not yet used AI at work

Yuvraj — Thu, 06 Nov 2025 11:56:43 +0000

AI tools are boosting productivity, but researchers raise concerns about trust and transparency in answers, representing a missed opportunity for R&D In its latest report, Researcher of the Future, Elsevier reveals that one-third (33%) of corporate researchers do not yet use AI for work. With time savings and future potential clear for current users, the report […]

The post New data from Elsevier finds one in three corporate researchers have not yet used AI at work first appeared on World Pharma Today.

Biopharmaceutical Formulation Stability Solutions

Yuvraj — Fri, 17 Oct 2025 13:17:00 +0000

Biopharmaceutical Formulation Challenges and Stability Solutions The biopharmaceutical revolution has fundamentally transformed therapeutic medicine, with protein-based therapeutics including monoclonal antibodies, fusion proteins, antibody-drug conjugates, and advanced biologic systems becoming cornerstones of treatment for cancer, autoimmune diseases, metabolic disorders, and numerous other conditions. Yet this transformation carries profound challenges related to biopharmaceutical formulation stability that distinguish […]

The post Biopharmaceutical Formulation Stability Solutions first appeared on World Pharma Today.

Overcoming Scale Up Bottlenecks in Cell Culture Bioprocesses

Yuvraj — Wed, 01 Oct 2025 11:36:33 +0000

Overcoming Scale Up Bottlenecks in Cell Culture and Downstream Processing In the rapidly evolving landscape of biopharmaceutical manufacturing, the journey from laboratory-scale success to commercial production represents one of the most challenging phases in bringing life-saving therapies to patients. Scale up bottlenecks in cell culture and downstream processing continue to present formidable obstacles that can […]

The post Overcoming Scale Up Bottlenecks in Cell Culture Bioprocesses first appeared on World Pharma Today.